{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:29:00Z","timestamp":1791890940622,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s11894-008-0003-1","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T14:03:36Z","timestamp":1201788216000},"page":"7-14","source":"Crossref","is-referenced-by-count":7,"title":["What\u2019s new in the treatment of ascites and spontaneous bacterial peritonitis"],"prefix":"10.1007","volume":"10","author":[{"given":"Andr\u00e9s","family":"C\u00e1rdenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,1]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"K.P. Moore","year":"2003","unstructured":"Moore KP, Wong F, Gin\u00e8s P, et al.: The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003, 38:258\u2013266.","journal-title":"Hepatology"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","volume":"350","author":"P. Gin\u00e8s","year":"2004","unstructured":"Gin\u00e8s P, C\u00e1rdenas A, Arroyo V, Rod\u00e9s J: Management of cirrhosis and ascites. N Engl J Med 2004, 350:1646\u20131654.","journal-title":"N Engl J Med"},{"issue":"Suppl6","key":"3_CR3","first-page":"vi1","volume":"55","author":"K.P. Moore","year":"2006","unstructured":"Moore KP, Aithal GP: Guidelines on the management of ascites in cirrhosis. Gut 2006, 55(Suppl 6):vi1\u2013vi12.","journal-title":"Gut"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/9780470987025.ch32","volume-title":"Evidence-based Gastroenterology and Hepatology","author":"P. Gin\u00e8s","year":"2004","unstructured":"Gin\u00e8s P, Arroyo V, Rod\u00e9s J: Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis. In Evidence-based Gastroenterology and Hepatology, 2nd edn. Edited by McDonald J WD, Burroughs AK, Feagan BG. London: BMJ Books; 2004:487\u2013503.","edition":"2nd edn."},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"V. Arroyo","year":"1996","unstructured":"Arroyo V, Gin\u00e8s P, Gerbes A, et al.: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996, 23:164\u2013176.","journal-title":"Hepatology"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM199109193251201","volume":"325","author":"P. Gin\u00e8s","year":"1991","unstructured":"Gin\u00e8s P, Arroyo V, Vargas V, et al.: Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991, 325:829\u2013835.","journal-title":"N Engl J Med"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","volume":"25","author":"D. Lebrec","year":"1996","unstructured":"Lebrec D, Giuily N, Hadengue A, et al.: Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996, 25:135\u2013144.","journal-title":"J Hepatol"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","volume":"342","author":"M. Rossle","year":"2000","unstructured":"Rossle M, Ochs A, Gulberg V, et al.: A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000, 342:1701\u20131707.","journal-title":"N Engl J Med"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","volume":"123","author":"P. Gin\u00e8s","year":"2002","unstructured":"Gin\u00e8s P, Uriz J, Calahorra B, et al.: Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002, 123:1839\u20131847.","journal-title":"Gastroenterology"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","volume":"124","author":"A. Sanyal","year":"2003","unstructured":"Sanyal A, Genning C, Reddy RK, et al.: The North American Study for Treatment of Refractory Ascites. Gastroenterology 2003, 124:634\u2013641.","journal-title":"Gastroenterology"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","volume":"40","author":"F. Salerno","year":"2004","unstructured":"Salerno F, Merli M, Riggio O, et al.: Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004, 40:629\u2013635.","journal-title":"Hepatology"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1478-3231.2005.01095.x","volume":"25","author":"P. Delterne","year":"2005","unstructured":"Delterne P, Mathurin P, Dharancy S, et al.: Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis. Liver Int 2005, 25:349\u2013356.","journal-title":"Liver Int"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jhep.2005.06.005","volume":"43","author":"A. Albillos","year":"2005","unstructured":"Albillos A, Ba\u00f1ares R, Gonz\u00e1les M, et al.: A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol 2005, 43: 990\u2013996.","journal-title":"J Hepatol"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2005.07.031","volume":"129","author":"G. D\u2019Amico","year":"2005","unstructured":"D\u2019Amico G, Luca A, Morabito A, et al.: Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology 2005, 129:1282\u20131293.","journal-title":"Gastroenterology"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","volume":"133","author":"F. Salerno","year":"2007","unstructured":"Salerno F, Camma C, Enea M, et al.: Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007, 133:825\u2013834.","journal-title":"Gastroenterology"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20559","volume":"41","author":"T.D. Boyer","year":"2005","unstructured":"Boyer TD, Haskal Z: The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005, 41:386\u2013400.","journal-title":"Hepatology"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/hep.21355","volume":"44","author":"A. Lenaerts","year":"2006","unstructured":"Lenaerts A, Codden T, Meunier JC, et al.: Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. Hepatology 2006, 44:844\u2013849.","journal-title":"Hepatology"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhep.2006.09.012","volume":"46","author":"G. Kalambokis","year":"2007","unstructured":"Kalambokis G, Fotopoulos A, Economou M, et al.: Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites. J Hepatol 2007, 46:213\u2013221.","journal-title":"J Hepatol"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jhep.2007.03.007","volume":"46","author":"P. Gin\u00e8s","year":"2007","unstructured":"Gin\u00e8s P: Vaptans: a promising therapy in the management of advanced cirrhosis. J Hepatol 2007, 46:1150\u20131152.","journal-title":"J Hepatol"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"180A","DOI":"10.1002\/hep.21307","volume":"44","author":"F. Wong","year":"2006","unstructured":"Wong F, Gin\u00e8s P, Watson HR, et al.: Effects of a selective vasopressin V2 receptor antagonist, satavaptan (SR121463B), on recurrence of ascites after large volume paracentesis [abstract]. Hepatology 2006, 44:180A.","journal-title":"Hepatology"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510280337","volume":"28","author":"P. Gin\u00e8s","year":"1998","unstructured":"Gin\u00e8s P, Berl T, Bernardi M, et al.: Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology 1998, 28:851\u2013864.","journal-title":"Hepatology"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","volume":"40","author":"D.M. Heuman","year":"2004","unstructured":"Heuman DM, Abou-assi SG, Habib A, et al.: Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004, 40:802\u2013810.","journal-title":"Hepatology"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.20517","volume":"41","author":"S. Biggins","year":"2005","unstructured":"Biggins S, Rodriguez HJ, Bachetti P, et al.: Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005, 41:32\u201339.","journal-title":"Hepatology"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/lt.20329","volume":"11","author":"A.E. Ruf","year":"2005","unstructured":"Ruf AE, Kremers WK, Chavez LL, et al.: Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005, 11:336\u2013343.","journal-title":"Liver Transpl"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","volume":"130","author":"S.W. Biggins","year":"2006","unstructured":"Biggins SW, Kim WR, Terrault NA, et al.: Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006, 130:1652\u20131660.","journal-title":"Gastroenterology"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/lt.21197","volume":"13","author":"A. Luca","year":"2007","unstructured":"Luca A, Angermayr B, Bertolini G, et al.: An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007, 13:1174\u20131180.","journal-title":"Liver Transpl"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.ki.5000432","volume":"69","author":"A. Greenberg","year":"2006","unstructured":"Greenberg A, Verbalis JG: Vasopressin receptor antagonists. Kidney Int 2006, 69:2124\u20132130.","journal-title":"Kidney Int"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","volume":"44","author":"P. Angeli","year":"2006","unstructured":"Angeli P, Wong F, Watson H, Gin\u00e8s P: Hyponatremia in cirrhosis: results of a patient population survey. Hepatology 2006, 44:1535\u20131542.","journal-title":"Hepatology"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1399-0012.1998.tb01102.x","volume":"12","author":"O. Abbasoglu","year":"1998","unstructured":"Abbasoglu O, Goldstein RM, Vodapally MS, et al.: Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant 1998, 12:263\u2013269.","journal-title":"Clin Transplant"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/00007890-198912000-00023","volume":"48","author":"Z.K. Wszolek","year":"1998","unstructured":"Wszolek ZK, McComb RD, Pfeiffer RF, et al.: Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium. Transplantation 1998, 48:1006\u20131012.","journal-title":"Transplantation"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","volume":"130","author":"M.C. Londo\u00f1o","year":"2006","unstructured":"Londo\u00f1o MC, Guevara M, Rimola A, et al.: Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006, 130:1135\u20131143.","journal-title":"Gastroenterology"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/lt.21154","volume":"13","author":"M.F. Dawas","year":"2007","unstructured":"Dawas MF, Lewsey JD, Neuberger J, et al.: The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl 2007, 13:1115\u20131124.","journal-title":"Liver Transpl"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2003.50021","volume":"37","author":"F. Wong","year":"2003","unstructured":"Wong F, Blei AT, Blendis LM, Thuluvath PJ: A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial. Hepatology 2003, 37:182\u2013191.","journal-title":"Hepatology"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/gast.2003.50143","volume":"124","author":"A.L. Gerbes","year":"2003","unstructured":"Gerbes AL, G\u00fclberg V, Gin\u00e8s P, et al.: Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 2003, 124:933\u2013939.","journal-title":"Gastroenterology"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"732A","DOI":"10.1016\/S0168-8278(06)80732-4","volume":"44","author":"P. Gin\u00e8s","year":"2006","unstructured":"Gin\u00e8s P, Wong F, Milutinovic S: Effects of satavaptan (SR121463B), a selective vasopressin V2 receptor antagonist on serum sodium concentration and ascites in patients with cirrhosis hyponatremia [abstract]. J Hepatol 2006, 44:732A.","journal-title":"J Hepatol"},{"issue":"Suppl1","key":"3_CR36","first-page":"90A","volume":"46","author":"P. Gin\u00e8s","year":"2007","unstructured":"Gin\u00e8s P, Wong F, Watson H: Long-term improvement of serum sodium by the V-2 receptor antagonist satavaptan in patients with cirrhosis and hyponatraemia [abstract]. J Hepatol 2007, 46(Suppl 1):90A.","journal-title":"J Hepatol"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"P. Gin\u00e8s","year":"2003","unstructured":"Gin\u00e8s P, Guevara M, Arroyo V, Rodes J: Hepatorenal syndrome. Lancet 2003, 362:1819\u20131827.","journal-title":"Lancet"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","volume":"41","author":"C. Alessandria","year":"2005","unstructured":"Alessandria C, Ozdogan O, Guevara M, et al.: MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005, 41:1282\u20131289.","journal-title":"Hepatology"},{"key":"3_CR39","first-page":"271","volume-title":"Ascites and Renal Dysfunction in Liver Disease","author":"A. Rimola","year":"2007","unstructured":"Rimola A, Navasa M, Grande L, Garc\u00eda-Valdecasas JC: Liver transplantation in patients with cirrhosis and ascites. In Ascites and Renal Dysfunction in Liver Disease. Edited by Gin\u00e8s P, Arroyo V, Rodes J, Schrier RW. Oxford: Blackwell; 2007:271\u2013285."},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.21094","volume":"43","author":"R. Moreau","year":"2006","unstructured":"Moreau R, Lebrec D: The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology 2006, 43:385\u2013394.","journal-title":"Hepatology"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","volume":"46","author":"V. Arroyo","year":"2007","unstructured":"Arroyo V, Terra C, Gin\u00e8s P: Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol 2007, 46:935\u2013946.","journal-title":"J Hepatol"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","volume":"27","author":"M. Guevara","year":"1998","unstructured":"Guevara M, Gin\u00e8s P, Fernandez-Esparrach G, et al.: Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 1998, 27:35\u201341.","journal-title":"Hepatology"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.510300430","volume":"30","author":"V. Gulberg","year":"1999","unstructured":"Gulberg V, Bilzer M, Gerbes AL: Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology 1999, 30:870\u2013875.","journal-title":"Hepatology"},{"key":"3_CR44","first-page":"694A","volume":"44","author":"A. Sanyal","year":"2006","unstructured":"Sanyal A, Boyer T, Garcia-Tsao G, et al.: A prospective, randomized, double blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome (HRS). Hepatology 2006, 44:694A.","journal-title":"Hepatology"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"82A","DOI":"10.1016\/S0168-8278(07)61680-8","volume":"46","author":"M. Martin-Llahi","year":"2007","unstructured":"Martin-Llahi M, Pepin MN, Guevara G, et al.: Randomized, comparative study of terlipressin and albumin vs. albumin alone in patients with cirrhosis and hepatorenal syndrome. J Hepatol 2007, 46:82A.","journal-title":"J Hepatol"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","volume":"36","author":"C. Duvoux","year":"2002","unstructured":"Duvoux C, Zanditenas D, Hezode C, et al.: Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 2002, 36:374\u2013380.","journal-title":"Hepatology"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","volume":"47","author":"C. Alessandria","year":"2007","unstructured":"Alessandria C, Ottobrelli A, Debernardi-Venon W, et al.: Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol 2007, 47:499\u2013505.","journal-title":"J Hepatol"},{"key":"3_CR48","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","volume":"14","author":"C. Alessandria","year":"2002","unstructured":"Alessandria C, Venon W, Marzano A: Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2. Eur J Gastroenterol Hepatol 2002, 14:1363\u20131368.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R. Ortega","year":"2002","unstructured":"Ortega R, Gin\u00e8s P, Uriz J, et al.: Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 2002, 36:941\u2013948.","journal-title":"Hepatology"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","volume":"47","author":"K.A. Brensing","year":"2000","unstructured":"Brensing KA, Textor J, Perz J, et al.: Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000, 47:288\u2013295.","journal-title":"Gut"},{"key":"3_CR51","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","volume":"28","author":"M. Guevara","year":"1998","unstructured":"Guevara M, Gin\u00e8s P, Bandi JC, et al.: Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998, 28:416\u2013422.","journal-title":"Hepatology"},{"key":"3_CR52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","volume":"6","author":"S.R. Mitzer","year":"2000","unstructured":"Mitzer SR, Stange J, Klammt S, et al.: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000, 6:277\u2013286.","journal-title":"Liver Transpl"},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000086552","volume":"23","author":"K. Rifai","year":"2005","unstructured":"Rifai K, Ernst T, Kretschmer U, et al.: The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 2005, 23:298\u2013302.","journal-title":"Blood Purif"},{"key":"3_CR54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J. Fern\u00e1ndez","year":"2002","unstructured":"Fern\u00e1ndez J, Navasa M, G\u00f3mez J, et al.: Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002, 35:140\u2013148.","journal-title":"Hepatology"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","volume":"32","author":"A. Rimola","year":"2000","unstructured":"Rimola A, Garcia-Tsao G, Navasa M, et al.: Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000, 32:142\u2013153.","journal-title":"J Hepatol"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1053\/jhep.2003.50120","volume":"37","author":"J. Castellote","year":"2003","unstructured":"Castellote J, L\u00f3pez C, Gornals J, et al.: Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology 2003, 37:893\u2013896.","journal-title":"Hepatology"},{"key":"3_CR57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1440-1746.2004.03554.x","volume":"20","author":"T. Sapey","year":"2005","unstructured":"Sapey T, Mena E, Fort E, et al.: Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center. J Gastroenterol Hepatol 2005, 20:187\u2013192.","journal-title":"J Gastroenterol Hepatol"},{"key":"3_CR58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MEG.0b013e328013e991","volume":"19","author":"D.R. Gaya","year":"2007","unstructured":"Gaya DR, David B, Lyon T, et al.: Bedside leucocyte esterase reagent strips with spectrophotometric analysis to rapidly exclude spontaneous bacterial peritonitis: a pilot study. Eur J Gastroenterol Hepatol 2007, 19:289\u2013295.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.21588","volume":"45","author":"J.B. Nousbaum","year":"2007","unstructured":"Nousbaum JB, Cadranel JF, Nahon P, et al.: Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology 2007, 45:1275\u20131281.","journal-title":"Hepatology"},{"key":"3_CR60","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/hep.21101","volume":"43","author":"M.H. Tsai","year":"2006","unstructured":"Tsai MH, Peng YS, Chen YC, et al.: Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 2006, 43:673\u2013681.","journal-title":"Hepatology"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/hep.21352","volume":"44","author":"J. Fern\u00e1ndez","year":"2006","unstructured":"Fern\u00e1ndez J, Escorsell A, Zabalza M, et al.: Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival. Hepatology 2006, 44:1288\u20131295.","journal-title":"Hepatology"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P. Sort","year":"1999","unstructured":"Sort P, Navasa M, Arroyo V, et al.: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999, 341:403\u2013409.","journal-title":"N Engl J Med"},{"key":"3_CR63","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.510290608","volume":"29","author":"B. Bernard","year":"1999","unstructured":"Bernard B, Grang\u00e9 JD, Nguyen K, et al.: Antibiotics prophylaxis in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999, 29:1655\u20131661.","journal-title":"Hepatology"},{"key":"3_CR64","doi-asserted-by":"crossref","unstructured":"Soares-Weiser K, Brezis M, Tur-Kaspa R, Leibovici L: Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002, (2):CD002907.","DOI":"10.1002\/14651858.CD002907"},{"key":"3_CR65","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.1840050320","volume":"5","author":"A. Rimola","year":"1995","unstructured":"Rimola A, Bory F, Ter\u00e9s J, et al.: Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1995, 5:463\u2013467.","journal-title":"Hepatology"},{"key":"3_CR66","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","volume":"131","author":"J. Fern\u00e1ndez","year":"2006","unstructured":"Fern\u00e1ndez J, Ruiz del Arbol L, Gomez C, et al.: Norfloxacin versus ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 2006, 131:1049\u20131056.","journal-title":"Gastroenterology"},{"key":"3_CR67","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","volume":"12","author":"P. Gin\u00e8s","year":"1990","unstructured":"Gin\u00e8s P, Rimola A, Planas R, et al.: Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double blind, placebo controlled trial. Hepatology, 1990, 12:716\u2013724.","journal-title":"Hepatology"},{"key":"3_CR68","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","volume":"133","author":"J. Fern\u00e1ndez","year":"2007","unstructured":"Fern\u00e1ndez J, Navasa M, Planas R, et al.: Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 2007, 133:818\u2013824.","journal-title":"Gastroenterology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0003-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-008-0003-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0003-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T14:08:58Z","timestamp":1737900538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-008-0003-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s11894-008-0003-1","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}